T-Pouch Orthotopic Ileal Neobladder
The T-pouch uses a serosa-lined tunnel around an ileal afferent limb to limit reflux into the ureters. Stein and colleagues began the USC series in 1996 and published the initial 40-patient experience in 1998.[1][2] The design avoids intussusception of the Kock afferent nipple.[1][2]
USC-STAR provides the main comparative evidence. This randomized comparison with the Studer pouch found no renal-function advantage at three years and more diversion-related secondary operations with the T-pouch.[3]
Construction and operative principles
USC-STAR used 44 cm detubularized, double-folded reservoirs, a separate tunneled afferent segment for the T-pouch, and separate Leadbetter/Bricker ureteral anastomoses.[3]
The T limb is an intact afferent ileal segment embedded in a serosa-lined tunnel formed from the detubularized ileal plate. The intended valve mechanism is compression of the afferent segment within the tunnel as reservoir pressure rises. Unlike the Kock nipple, the tunnel does not require intussusception, and the blood supply to the afferent segment is preserved. The inlet should not be narrow, twisted or angulated. The reservoir needs a dependent, tension-free urethral anastomosis and reliable low-pressure emptying.[1][2]
Stein describes opening four mesenteric windows of Deaver along the distal 4 cm of the afferent segment, between and preserving the vascular arcades, and passing small Penrose drains through the windows to guide suture placement; two to three silk sutures through each window anchor the afferent segment between the seromuscular edges of the adjacent reservoir limbs to form the reservoir's posterior backboard. His group initially tapered the distal segment routinely over a 30 Fr catheter, then limited tapering to afferent segments with an obviously large diameter.[10]
Bochner's pig-model experiments tested four valve configurations (18 and 30 Fr, in 1 and 2 cm tunnels). No valve leaked immediately after construction, including with external compression to an intrareservoir pressure of 100 cm H₂O. After four weeks, a 30 Fr valve in a 1 cm tunnel leaked at a reservoir pressure of 19 cm H₂O. Increasing that tunnel to 2 cm (tunnel length-to-diameter ratio 2:1) eliminated leakage up to 100 cm H₂O.[5]
Selection, bowel preparation, metabolic risk and the patient's ability to manage incomplete emptying are covered in the diversion principles.
USC-STAR randomized comparison
This unmasked, single-center bladder-cancer trial randomized 484 patients between February 2002 and November 2009: 237 T-pouch and 247 Studer. The primary endpoint was the change in CKD-EPI eGFR from baseline to three years. Complete baseline data were available for 423, with 260 remaining for three-year renal assessment.[3]
| Outcome at three years | T-pouch | Studer |
|---|---|---|
| Mean eGFR change from baseline | −6.6 mL/min/1.73 m² | −6.4 mL/min/1.73 m²; between-group p = 0.35 |
| Cumulative incidence of diversion-related surgical reintervention | 22% | 13%; p < 0.01 |
| Symptomatic or treated UTI | No significant between-group difference | No significant between-group difference |
Source: Skinner 2015.[3] In multivariable analysis, neobladder type was not independently associated with three-year renal function (p = 0.63). Baseline eGFR, age and urinary tract obstruction were. Overall late complications did not differ between arms, but the excess diversion-related reinterventions in the T-pouch arm included treatment of afferent-limb stenosis, pouch stones, ureteral strictures and urethral or bladder-neck strictures.[3] These results argue against adding the T-valve solely for three-year renal protection. Missing data and survival to assessment limit interpretation.
A separate 60-patient randomized trial compared a serous-lined extramural ureteral tunnel with a T-limb. Follow-up included 27 patients/49 renal units and 23 patients/45 renal units, respectively. Reflux occurred in 0 versus 13 renal units (29%), with one ureteroileal stricture in each group. Progressive renal cortical scarring, with or without a >25% GFR decline, occurred in 3/49 renal units in the tunnel arm and 4/45 in the T-limb arm.[4][4]
Intermediate T-pouch cohort
Stein's 209-patient series included 169 men and 40 women, with median follow-up of 33 months. Stein reported functional outcomes only among evaluable patients.[2]
| Finding | Reported result |
|---|---|
| Good daytime / nighttime continence | 87% / 72% of evaluable patients |
| Intermittent catheterization for complete emptying | 25% overall; 20% of men and 43% of women |
| Reflux on gravity cystography | 15/158 evaluable patients |
| Normal or decompressed upper tracts | 162/181 imaged patients |
| Stable or improved serum-creatinine-based renal function | 96% |
| Perioperative death | 3/209 (1.4%) |
| Early complications (within 3 months) | 63 (30%): 53 unrelated to the diversion (dehydration most common) and 10 related (urine leak in 6); none directly related to the T limb |
| Late complications | 68 (32%): 30 unrelated (incisional hernia in 16) and 38 related to the diversion |
| Late pouch calculi | 17 patients |
| Late ureteroileal obstruction | 9 patients |
| T-limb stenosis | 4 patients; 3 had received adjuvant pelvic radiation |
Source: Stein 2004.[2] The sex difference in catheterization is a cohort finding; contemporary risk depends on anatomy, preservation of support, emptying function and follow-up.
Why continence definitions matter
Ahmadi's later mailed questionnaire included male participants from both USC-STAR arms, with a 68% response rate and mean follow-up of 4.5 years. Among respondents, 47% used at least one pad in the daytime and 72% at night. Overall, 22.3% used no pads, 62.5% reported mucus leakage and 9.5% performed intermittent catheterization. Increasing age and diabetes were predictors of urinary function but did not affect pad use.[6]
Kretschmer's separate cohort combined questionnaires with standardized pad tests. Of 244 patients contacted, 188 responded; continence required at most one safety pad and urine loss of no more than 10 g per test. Reported daytime and nighttime continence were 54.3% and 36.3%.[7]
Related adaptations
The T-valve can also serve as a catheterizable efferent continence mechanism, which is a different role from preventing reflux in an orthotopic neobladder. Marino's 18-patient cutaneous series (mean age 68 years, mean follow-up 12 months) used the valve with a Mitrofanoff-type channel. All patients were continent day and night, catheterization was uncomplicated with evacuation intervals of about 4 hours, and no late complications were reported. The simplified technique preserved about 13 cm of ileum.[8]
The same design concept has been used in a continent ileostomy for stool. Kaiser's 40-patient report had median follow-up of 6.2 years, with good continence reported in 92%, but major pouch-related abdominal surgery in 30% and minor stoma procedures in 25%. Pouch intubation was needed about four times daily, and 87.5% would have the surgery again. Kaiser's outcomes are limited to fecal pouches.[9]
Follow-up and counseling
Follow the diversion surveillance framework: assess emptying, continence, renal function, electrolytes and acid–base status and the upper tracts. New hydronephrosis requires assessment for ureteroileal or T-limb obstruction, even with an antireflux mechanism. Discuss catheterization, stones and reintervention alongside continence goals.[2][3]
See Also
References
1. Stein JP, Lieskovsky G, Ginsberg DA, Bochner BH, Skinner DG. "The T pouch: an orthotopic ileal neobladder incorporating a serosal-lined ileal antireflux technique." J Urol. 1998;159(6):1836–1842. doi:10.1016/S0022-5347(01)63170-7
2. Stein JP, Dunn MD, Quek ML, Miranda G, Skinner DG. "The orthotopic T pouch ileal neobladder: experience with 209 patients." J Urol. 2004;172(2):584–587. doi:10.1097/01.ju.0000131651.77048.73
3. Skinner EC, Fairey AS, Groshen S, et al. "Randomized trial of Studer pouch versus T-pouch orthotopic ileal neobladder in patients with bladder cancer." J Urol. 2015;194(2):433–439. doi:10.1016/j.juro.2015.03.101
4. Osman Y, Abol-Enein H, El-Mekresh M, et al. "Comparison between a serous-lined extramural tunnel and T-limb ileal procedure as an antireflux technique in orthotopic ileal substitutes: a prospective randomized trial." BJU Int. 2009;104(10):1518–1521. doi:10.1111/j.1464-410X.2009.08574.x
5. Bochner BH, Stein JP, Ginsberg DA, et al. "A serous-lined antireflux valve: in vivo fluorourodynamic evaluation of antireflux continence mechanism." J Urol. 1998;160(1):112–115. doi:10.1016/s0022-5347(01)63049-0
6. Ahmadi H, Skinner EC, Simma-Chiang V, et al. "Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients." J Urol. 2013;189(5):1782–1788. doi:10.1016/j.juro.2012.11.078
7. Kretschmer A, Grimm T, Buchner A, et al. "Prognostic features for objectively defined urinary continence after radical cystectomy and ileal orthotopic neobladder in a contemporary cohort." J Urol. 2017;197(1):210–215. doi:10.1016/j.juro.2016.08.004
8. Marino G, Laudi M. "Ileal T-pouch as a urinary continent cutaneous diversion: clinical and urodynamic evaluation." BJU Int. 2002;90(1):47–50. doi:10.1046/j.1464-410x.2002.02784.x
9. Kaiser AM. "T-pouch: results of the first 10 years with a non-intussuscepting continent ileostomy." Dis Colon Rectum. 2012;55(2):155–162. doi:10.1097/DCR.0b013e31823a969b
10. Stein JP. Ileal neobladder: T-pouch. In: Montague DK, Gill IS, Angermeier KW, Ross JH, eds. Textbook of Reconstructive Urologic Surgery. Informa Healthcare; 2008:325–335.